| Year |
Citation |
Score |
| 2024 |
Wooliscroft L, Salter A, Adusumilli G, Levasseur VA, Sun P, Lancia S, Perantie DC, Trinkaus K, Naismith RT, Song SK, Cross AH. Diffusion basis spectrum imaging and diffusion tensor imaging predict persistent black hole formation in multiple sclerosis. Multiple Sclerosis and Related Disorders. 84: 105494. PMID 38359694 DOI: 10.1016/j.msard.2024.105494 |
0.301 |
|
| 2024 |
Perez-Paramo YX, Dufield D, Veeramachaneni R, Parkhurst E, Harp C, Ramesh A, Winger RC, Cross AH, Gelfand JM, Bar-Or A, Mathews WR, Anania VG. Development of an LC-MS/MS method to measure sphingolipids in CSF from patients with multiple sclerosis. Molecular Pharmacology. PMID 38182433 DOI: 10.1124/molpharm.123.000779 |
0.318 |
|
| 2023 |
Jiang H, Zhou C, Qiu L, Gropler RJ, Brier MR, Wu GF, Cross AH, Perlmutter JS, Benzinger TLS, Tu Z. Quantitative Analysis of S1PR1 Expression in the Postmortem Multiple Sclerosis Central Nervous System. Acs Chemical Neuroscience. 14: 4039-4050. PMID 37882753 DOI: 10.1021/acschemneuro.3c00581 |
0.393 |
|
| 2023 |
Cantoni C, Ghezzi L, Choi J, Cross AH, Piccio L. Targeting miR-223 enhances myeloid-derived suppressor cell suppressive activities in multiple sclerosis patients. Multiple Sclerosis and Related Disorders. 76: 104839. PMID 37364375 DOI: 10.1016/j.msard.2023.104839 |
0.768 |
|
| 2023 |
Williams MJ, Okai AF, Cross AH, Monson NL, Vartanian T, Thrower BW, Reder AT, English JB, Wu GF, Bernitsas E, Yap S, Ndrio J, Pei J, Mowry EM, Magrini F, et al. Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trial. Multiple Sclerosis and Related Disorders. 76: 104794. PMID 37356256 DOI: 10.1016/j.msard.2023.104794 |
0.329 |
|
| 2023 |
Samara A, Cantoni C, Piccio L, Cross AH, Chahin S. Obesity, gut microbiota, and multiple sclerosis: Unraveling the connection. Multiple Sclerosis and Related Disorders. 76: 104768. PMID 37269641 DOI: 10.1016/j.msard.2023.104768 |
0.794 |
|
| 2023 |
Brier MR, Li Z, Ly M, Karim HT, Liang L, Du W, McCarthy JE, Cross AH, Benzinger TLS, Naismith RT, Chahin S. "Brain age" predicts disability accumulation in multiple sclerosis. Annals of Clinical and Translational Neurology. PMID 37119507 DOI: 10.1002/acn3.51782 |
0.74 |
|
| 2023 |
Brier MR, Xiang B, Ciotti JR, Chahin S, Wu GF, Naismith RT, Yablonskiy D, Cross AH. Quantitative MRI identifies lesional and non-lesional abnormalities in MOGAD. Multiple Sclerosis and Related Disorders. 73: 104659. PMID 37004272 DOI: 10.1016/j.msard.2023.104659 |
0.827 |
|
| 2023 |
Ghezzi L, Bollman B, De Feo L, Piccio L, Trapp BD, Schmidt RE, Cross AH. Schwann Cell Remyelination in the Multiple Sclerosis Central Nervous System. Laboratory Investigation; a Journal of Technical Methods and Pathology. 100128. PMID 36889543 DOI: 10.1016/j.labinv.2023.100128 |
0.786 |
|
| 2022 |
Xiang B, Wen J, Schmidt RE, Sukstanskii AL, Mamah D, Yablonskiy DA, Cross AH. Evaluating brain damage in multiple sclerosis with simultaneous multi-angular-relaxometry of tissue. Annals of Clinical and Translational Neurology. PMID 36178006 DOI: 10.1002/acn3.51621 |
0.646 |
|
| 2022 |
Longbrake EE, Hua LH, Mowry EM, Gauthier SA, Alvarez E, Cross AH, Pei J, Priest J, Raposo C, Hafler DA, Winger RC. The CELLO trial: Protocol of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndrome. Multiple Sclerosis and Related Disorders. 68: 104143. PMID 36031693 DOI: 10.1016/j.msard.2022.104143 |
0.575 |
|
| 2022 |
Aloisi F, Cross AH. MINI-review of Epstein-Barr virus involvement in multiple sclerosis etiology and pathogenesis. Journal of Neuroimmunology. 371: 577935. PMID 35931008 DOI: 10.1016/j.jneuroim.2022.577935 |
0.338 |
|
| 2022 |
Naismith RT, Cross AH. Further support for rituximab in relapsing multiple sclerosis. The Lancet. Neurology. 21: 672-673. PMID 35841895 DOI: 10.1016/S1474-4422(21)00180-0 |
0.759 |
|
| 2022 |
Solomon AJ, Arrambide G, Brownlee W, Cross AH, Gaitan MI, Lublin FD, Makhani N, Mowry EM, Reich DS, Rovira À, Weinshenker BG, Cohen JA. Confirming a Historical Diagnosis of Multiple Sclerosis: Challenges and Recommendations. Neurology. Clinical Practice. 12: 263-269. PMID 35747540 DOI: 10.1212/CPJ.0000000000001149 |
0.318 |
|
| 2022 |
Ziemssen T, Arnold DL, Alvarez E, Cross AH, Willi R, Li B, Kukkaro P, Kropshofer H, Ramanathan K, Merschhemke M, Kieseier B, Su W, Häring DA, Hauser SL, Kappos L, et al. Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II Trials. Frontiers in Immunology. 13: 852563. PMID 35432382 DOI: 10.3389/fimmu.2022.852563 |
0.498 |
|
| 2022 |
Levasseur VA, Xiang B, Salter A, Yablonskiy DA, Cross AH. Stronger Microstructural Damage Revealed in Multiple Sclerosis Lesions With Central Vein Sign by Quantitative Gradient Echo MRI. Journal of Central Nervous System Disease. 14: 11795735221084842. PMID 35370433 DOI: 10.1177/11795735221084842 |
0.636 |
|
| 2022 |
Xiang B, Brier MR, Kanthamneni M, Wen J, Snyder AZ, Yablonskiy DA, Cross AH. Tissue damage detected by quantitative gradient echo MRI correlates with clinical progression in non-relapsing progressive MS. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585211073761. PMID 35196933 DOI: 10.1177/13524585211073761 |
0.644 |
|
| 2022 |
Cantoni C, Lin Q, Dorsett Y, Ghezzi L, Liu Z, Pan Y, Chen K, Han Y, Li Z, Xiao H, Gormley M, Liu Y, Bokoliya S, Panier H, Suther C, ... ... Cross AH, et al. Alterations of host-gut microbiome interactions in multiple sclerosis. Ebiomedicine. 76: 103798. PMID 35094961 DOI: 10.1016/j.ebiom.2021.103798 |
0.753 |
|
| 2021 |
Thompson AJ, Carroll W, Ciccarelli O, Comi G, Cross A, Donnelly A, Feinstein A, Fox RJ, Helme A, Hohlfeld R, Hyde R, Kanellis P, Landsman D, Lubetzki C, Marrie RA, et al. Charting a global research strategy for progressive MS-An international progressive MS Alliance proposal. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585211059766. PMID 34850641 DOI: 10.1177/13524585211059766 |
0.356 |
|
| 2021 |
Shah S, Locca A, Dorsett Y, Cantoni C, Ghezzi L, Lin Q, Bokoliya S, Panier H, Suther C, Gormley M, Liu Y, Evans E, Mikesell R, Obert K, Salter A, ... Cross AH, et al. Alterations of the gut mycobiome in patients with MS. Ebiomedicine. 71: 103557. PMID 34455391 DOI: 10.1016/j.ebiom.2021.103557 |
0.779 |
|
| 2021 |
Brier MR, Snyder AZ, Tanenbaum A, Rudick RA, Fisher E, Jones S, Shimony JS, Cross AH, Benzinger TLS, Naismith RT. Quantitative signal properties from standardized MRIs correlate with multiple sclerosis disability. Annals of Clinical and Translational Neurology. PMID 33943045 DOI: 10.1002/acn3.51354 |
0.767 |
|
| 2021 |
Cross AH, Naismith RT. MS can be considered a primary progressive disease in all cases, but some patients have superimposed relapses - No. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585211001564. PMID 33874812 DOI: 10.1177/13524585211001564 |
0.749 |
|
| 2021 |
Ciotti JR, Eby NS, Brier MR, Wu GF, Chahin S, Cross AH, Naismith RT. Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585211007086. PMID 33870786 DOI: 10.1177/13524585211007086 |
0.743 |
|
| 2021 |
Fontana L, Ghezzi L, Cross AH, Piccio L. Effects of dietary restriction on neuroinflammation in neurodegenerative diseases. The Journal of Experimental Medicine. 218. PMID 33416892 DOI: 10.1084/jem.20190086 |
0.733 |
|
| 2020 |
Roach CA, Cross AH. Anti-CD20 B Cell Treatment for Relapsing Multiple Sclerosis. Frontiers in Neurology. 11: 595547. PMID 33551958 DOI: 10.3389/fneur.2020.595547 |
0.306 |
|
| 2020 |
Ciotti JR, Valtcheva MV, Cross AH. Effects of MS disease-modifying therapies on responses to vaccinations: A review. Multiple Sclerosis and Related Disorders. 45: 102439. PMID 32769063 DOI: 10.1016/J.Msard.2020.102439 |
0.303 |
|
| 2020 |
Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, et al. Ofatumumab versus Teriflunomide in Multiple Sclerosis. The New England Journal of Medicine. 383: 546-557. PMID 32757523 DOI: 10.1056/Nejmoa1917246 |
0.364 |
|
| 2020 |
Ciotti JR, Eby NS, Wu GF, Naismith RT, Chahin S, Cross AH. Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica. Multiple Sclerosis and Related Disorders. 45: 102399. PMID 32702642 DOI: 10.1016/J.Msard.2020.102399 |
0.768 |
|
| 2020 |
Esaulova E, Cantoni C, Shchukina I, Zaitsev K, Bucelli RC, Wu GF, Artyomov MN, Cross AH, Edelson BT. Single-cell RNA-seq analysis of human CSF microglia and myeloid cells in neuroinflammation. Neurology(R) Neuroimmunology & Neuroinflammation. 7. PMID 32371549 DOI: 10.1212/Nxi.0000000000000732 |
0.377 |
|
| 2020 |
Xiang B, Wen J, Lu HC, Schmidt RE, Yablonskiy DA, Cross AH. In vivo evolution of biopsy-proven inflammatory demyelination quantified by R2t* mapping. Annals of Clinical and Translational Neurology. PMID 32367692 DOI: 10.1002/Acn3.51052 |
0.61 |
|
| 2020 |
Ye Z, George A, Wu AT, Niu X, Lin J, Adusumilli G, Naismith RT, Cross AH, Sun P, Song SK. Deep learning with diffusion basis spectrum imaging for classification of multiple sclerosis lesions. Annals of Clinical and Translational Neurology. PMID 32304291 DOI: 10.1002/Acn3.51037 |
0.803 |
|
| 2020 |
Magliozzi R, Cross AH. Can CSF biomarkers predict future MS disease activity and severity? Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519871818. PMID 31965889 DOI: 10.1177/1352458519871818 |
0.449 |
|
| 2020 |
Sun P, George A, Perantie DC, Trinkaus K, Ye Z, Naismith RT, Song SK, Cross AH. Diffusion basis spectrum imaging provides insights into MS pathology. Neurology(R) Neuroimmunology & Neuroinflammation. 7. PMID 31871296 DOI: 10.1212/Nxi.0000000000000655 |
0.806 |
|
| 2019 |
Samudralwar RD, Spec A, Cross AH. Case Report: Fingolimod and Cryptococcosis: Collision of Immunomodulation with Infectious Disease. International Journal of Ms Care. 21: 275-280. PMID 31889932 DOI: 10.7224/1537-2073.2018-080 |
0.405 |
|
| 2019 |
Ciotti JR, Sanders N, Salter A, Berger JR, Cross AH, Chahin S. Clinical instrument to retrospectively capture levels of EDSS. Multiple Sclerosis and Related Disorders. 39: 101884. PMID 31865272 DOI: 10.1016/J.Msard.2019.101884 |
0.383 |
|
| 2019 |
Shirani A, Sun P, Trinkaus K, Perantie DC, George A, Naismith RT, Schmidt RE, Song SK, Cross AH. Diffusion basis spectrum imaging for identifying pathologies in MS subtypes. Annals of Clinical and Translational Neurology. PMID 31588688 DOI: 10.1002/Acn3.50903 |
0.818 |
|
| 2019 |
Evans E, Levasseur V, Cross AH, Piccio L. An overview of the current state of evidence for the role of specific diets in multiple sclerosis. Multiple Sclerosis and Related Disorders. 36: 101393. PMID 31574403 DOI: 10.1016/J.Msard.2019.101393 |
0.784 |
|
| 2019 |
Ghezzi L, Cantoni C, Cignarella F, Bollman B, Cross AH, Salter A, Galimberti D, Cella M, Piccio L. T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519852092. PMID 31237799 DOI: 10.1177/1352458519852092 |
0.799 |
|
| 2019 |
Astafiev SV, Wen J, Brody DL, Cross AH, Anokhin AP, Zinn KL, Corbetta M, Yablonskiy DA. A Novel Gradient Echo Plural Contrast Imaging Method Detects Brain Tissue Abnormalities in Patients With TBI Without Evident Anatomical Changes on Clinical MRI: A Pilot Study. Military Medicine. 184: 218-227. PMID 30901451 DOI: 10.1093/Milmed/Usy394 |
0.587 |
|
| 2019 |
Shirani A, Cross AH, Naismith RT. The association between handedness and clinicodemographic characteristics in people with multiple sclerosis: a brief report. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 5: 2055217319832031. PMID 30834138 DOI: 10.1177/2055217319832031 |
0.735 |
|
| 2018 |
Waubant E, Amezcua L, Sicotte N, Hellwig K, Krupp L, Weinstock-Guttman B, Yeh A, Lucas RM, Longbrake EE, Yadav V, Rensel M, Mar S, Hersh C, Block V, Zipp F, ... ... Cross AH, et al. Gender Inequities in the Multiple Sclerosis Community: A Call for Action Annals of Neurology. 84: 958-959. PMID 30387521 DOI: 10.1002/Ana.25359 |
0.317 |
|
| 2018 |
Solomon AJ, Naismith RT, Cross AH. Misdiagnosis of multiple sclerosis: Impact of the 2017 McDonald criteria on clinical practice. Neurology. PMID 30381369 DOI: 10.1212/Wnl.0000000000006583 |
0.776 |
|
| 2018 |
Xiang B, Wen J, Cross AH, Yablonskiy DA. Single scan quantitative gradient recalled echo MRI for evaluation of tissue damage in lesions and normal appearing gray and white matter in multiple sclerosis. Journal of Magnetic Resonance Imaging : Jmri. PMID 30155934 DOI: 10.1002/Jmri.26218 |
0.679 |
|
| 2018 |
Shirani A, Sun P, Schmidt RE, Trinkaus K, Naismith RT, Song SK, Cross AH. Histopathological correlation of diffusion basis spectrum imaging metrics of a biopsy-proven inflammatory demyelinating brain lesion: A brief report. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518786072. PMID 29992856 DOI: 10.1177/1352458518786072 |
0.801 |
|
| 2018 |
Shirani A, Wu GF, Giannini C, Cross AH. A case of oligodendroglioma and multiple sclerosis: Occam's razor or Hickam's dictum? Bmj Case Reports. 2018. PMID 29954769 DOI: 10.1136/Bcr-2018-225318 |
0.44 |
|
| 2018 |
Cignarella F, Cantoni C, Ghezzi L, Salter A, Dorsett Y, Chen L, Phillips D, Weinstock GM, Fontana L, Cross AH, Zhou Y, Piccio L. Intermittent Fasting Confers Protection in CNS Autoimmunity by Altering the Gut Microbiota. Cell Metabolism. 27: 1222-1235.e6. PMID 29874567 DOI: 10.1016/J.Cmet.2018.05.006 |
0.779 |
|
| 2018 |
Evans E, Piccio L, Cross AH. Use of Vitamins and Dietary Supplements by Patients With Multiple Sclerosis: A Review. Jama Neurology. PMID 29710293 DOI: 10.1001/Jamaneurol.2018.0611 |
0.755 |
|
| 2018 |
Ciotti JR, Cross AH. Disease-Modifying Treatment in Progressive Multiple Sclerosis. Current Treatment Options in Neurology. 20: 12. PMID 29627873 DOI: 10.1007/S11940-018-0496-3 |
0.484 |
|
| 2017 |
Cross AH, Naismith RT. Refining the use of MRI to predict multiple sclerosis. The Lancet. Neurology. PMID 29275978 DOI: 10.1016/S1474-4422(17)30459-3 |
0.744 |
|
| 2017 |
Adusumilli G, Trinkaus K, Sun P, Lancia S, Viox JD, Wen J, Naismith RT, Cross AH. Intensity ratio to improve black hole assessment in multiple sclerosis. Multiple Sclerosis and Related Disorders. 19: 140-147. PMID 29223871 DOI: 10.1016/J.Msard.2017.11.020 |
0.743 |
|
| 2017 |
Wen J, Yablonskiy DA, Salter A, Cross AH. Limbic system damage in MS: MRI assessment and correlations with clinical testing. Plos One. 12: e0187915. PMID 29121642 DOI: 10.1371/Journal.Pone.0187915 |
0.667 |
|
| 2017 |
Klawiter EC, Bove R, Elsone L, Alvarez E, Borisow N, Cortez M, Mateen F, Mealy MA, Sorum J, Mutch K, Tobyne SM, Ruprecht K, Buckle G, Levy M, Wingerchuk D, ... ... Cross AH, et al. High risk of postpartum relapses in neuromyelitis optica spectrum disorder. Neurology. PMID 29093070 DOI: 10.1212/Wnl.0000000000004681 |
0.673 |
|
| 2017 |
Baldassari LE, Salter AR, Longbrake EE, Cross AH, Naismith RT. Streamlined EDSS for use in multiple sclerosis clinical practice: Development and cross-sectional comparison to EDSS. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517721357. PMID 28766993 DOI: 10.1177/1352458517721357 |
0.732 |
|
| 2017 |
Longbrake EE, Cantoni C, Chahin S, Cignarella F, Cross AH, Piccio L. Dimethyl fumarate induces changes in B- and T-lymphocyte function independent of the effects on absolute lymphocyte count. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517707069. PMID 28480794 DOI: 10.1177/1352458517707069 |
0.744 |
|
| 2017 |
Klein RS, Voskuhl R, Segal BM, Dittel BN, Lane TE, Bethea JR, Carson MJ, Colton C, Rosi S, Anderson A, Piccio L, Goverman JM, Benveniste EN, Brown MA, Tiwari-Woodruff SK, ... ... Cross AH, et al. Speaking out about gender imbalance in invited speakers improves diversity. Nature Immunology. 18: 475-478. PMID 28418385 DOI: 10.1038/Ni.3707 |
0.734 |
|
| 2017 |
Lin TH, Chiang CW, Perez-Torres CJ, Sun P, Wallendorf M, Schmidt RE, Cross AH, Song SK. Diffusion MRI quantifies early axonal loss in the presence of nerve swelling. Journal of Neuroinflammation. 14: 78. PMID 28388913 DOI: 10.1186/S12974-017-0852-3 |
0.595 |
|
| 2017 |
Bove R, Elsone L, Alvarez E, Borisow N, Cortez MM, Mateen FJ, Mealy MA, Mutch K, Tobyne S, Ruprecht K, Buckle G, Levy M, Wingerchuk DM, Paul F, Cross AH, et al. Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study. Neurology(R) Neuroimmunology & Neuroinflammation. 4: e339. PMID 28382320 DOI: 10.1212/Nxi.0000000000000339 |
0.675 |
|
| 2016 |
Cross AH, Song SK. "A new imaging modality to non-invasively assess multiple sclerosis pathology". Journal of Neuroimmunology. PMID 27773433 DOI: 10.1016/J.Jneuroim.2016.10.002 |
0.576 |
|
| 2016 |
Solomon AJ, Bourdette DN, Cross AH, Applebee A, Skidd PM, Howard DB, Spain RI, Cameron MH, Kim E, Mass MK, Yadav V, Whitham RH, Longbrake EE, Naismith RT, Wu GF, et al. The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study. Neurology. PMID 27581217 DOI: 10.1212/Wnl.0000000000003152 |
0.787 |
|
| 2016 |
Lyons JA, Riter MM, Almatrook AM, Ramsbottom MJ, Cross AH. Amelioration of EAE by a cryptic epitope of myelin oligodendrocyte glycoprotein. Journal of Neuroimmunology. PMID 27423965 DOI: 10.1016/J.Jneuroim.2016.06.006 |
0.305 |
|
| 2016 |
Choi IY, Piccio L, Childress P, Bollman B, Ghosh A, Brandhorst S, Suarez J, Michalsen A, Cross AH, Morgan TE, Wei M, Paul F, Bock M, Longo VD. A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms. Cell Reports. PMID 27239035 DOI: 10.1016/J.Celrep.2016.05.009 |
0.793 |
|
| 2016 |
Zhao Y, Wen J, Cross AH, Yablonskiy DA. On the Relationship between Cellular and Hemodynamic Properties of the Human Brain Cortex throughout Adult Lifespan. Neuroimage. PMID 26997360 DOI: 10.1016/J.Neuroimage.2016.03.022 |
0.569 |
|
| 2016 |
Sukstanskii AL, Wen J, Cross AH, Yablonskiy DA. Simultaneous multiangular relaxometry of tissue with MRI (SMART MRI): Theoretical background and proof of concept. Magnetic Resonance in Medicine. PMID 26991525 DOI: 10.1002/Mrm.26176 |
0.567 |
|
| 2015 |
Alvarez E, Piccio L, Mikesell RJ, Trinkaus K, Parks BJ, Naismith RT, Cross AH. Predicting optimal response to B-cell depletion with rituximab in multiple sclerosis using CXCL13 index, magnetic resonance imaging and clinical measures. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 1: 2055217315623800. PMID 28607711 DOI: 10.1177/2055217315623800 |
0.798 |
|
| 2015 |
Patel KR, Luo J, Alvarez E, Piccio L, Schmidt RE, Yablonskiy DA, Cross AH. Detection of cortical lesions in multiple sclerosis: A new imaging approach. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 1: 2055217315606465. PMID 28607704 DOI: 10.1177/2055217315606465 |
0.82 |
|
| 2015 |
Wen J, Yablonskiy DA, Luo J, Lancia S, Hildebolt C, Cross AH. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI. Neuroimage. Clinical. 9: 164-75. PMID 27330979 DOI: 10.1016/J.Nicl.2015.08.003 |
0.699 |
|
| 2015 |
Longbrake EE, Cross AH. Effect of Multiple Sclerosis Disease-Modifying Therapies on B Cells and Humoral Immunity. Jama Neurology. 1-7. PMID 26720195 DOI: 10.1001/Jamaneurol.2015.3977 |
0.386 |
|
| 2015 |
Voskuhl RR, Wang H, Wu TC, Sicotte NL, Nakamura K, Kurth F, Itoh N, Bardens J, Bernard JT, Corboy JR, Cross AH, Dhib-Jalbut S, Ford CC, Frohman EM, Giesser B, et al. Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial. The Lancet. Neurology. PMID 26621682 DOI: 10.1016/S1474-4422(15)00322-1 |
0.413 |
|
| 2015 |
Longbrake EE, Naismith RT, Parks BJ, Wu GF, Cross AH. Dimethyl fumarate-associated lymphopenia: Risk factors and clinical significance. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 1. PMID 26550483 DOI: 10.1177/2055217315596994 |
0.752 |
|
| 2015 |
Longbrake EE, Ramsbottom MJ, Cantoni C, Ghezzi L, Cross AH, Piccio L. Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26459150 DOI: 10.1177/1352458515608961 |
0.79 |
|
| 2015 |
Naismith RT, Cross AH. Enhancing our understanding of white matter changes in early multiple sclerosis. Brain : a Journal of Neurology. 138: 2465-6. PMID 26304148 DOI: 10.1093/Brain/Awv196 |
0.762 |
|
| 2015 |
Wang Y, Sun P, Wang Q, Trinkaus K, Schmidt RE, Naismith RT, Cross AH, Song SK. Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis. Brain : a Journal of Neurology. 138: 1223-38. PMID 25724201 DOI: 10.1093/Brain/Awv046 |
0.808 |
|
| 2015 |
Cantoni C, Bollman B, Licastro D, Xie M, Mikesell R, Schmidt R, Yuede CM, Galimberti D, Olivecrona G, Klein RS, Cross AH, Otero K, Piccio L. TREM2 regulates microglial cell activation in response to demyelination in vivo. Acta Neuropathologica. 129: 429-47. PMID 25631124 DOI: 10.1007/S00401-015-1388-1 |
0.784 |
|
| 2015 |
Wen J, Yablonskiy DA, Luo J, Lancia S, Hildebolt C, Cross AH. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI Neuroimage: Clinical. 9: 164-175. DOI: 10.1016/j.nicl.2015.08.003 |
0.648 |
|
| 2014 |
Naismith RT, Cross AH. Antisense therapy: potential tool to reduce activity in MS via protein expression inhibition. Neurology. 83: 1776-7. PMID 25239837 DOI: 10.1212/Wnl.0000000000000927 |
0.719 |
|
| 2014 |
Chiang CW, Wang Y, Sun P, Lin TH, Trinkaus K, Cross AH, Song SK. Quantifying white matter tract diffusion parameters in the presence of increased extra-fiber cellularity and vasogenic edema. Neuroimage. 101: 310-9. PMID 25017446 DOI: 10.1016/J.Neuroimage.2014.06.064 |
0.539 |
|
| 2014 |
Lin TH, Kim JH, Perez-Torres C, Chiang CW, Trinkaus K, Cross AH, Song SK. Axonal transport rate decreased at the onset of optic neuritis in EAE mice. Neuroimage. 100: 244-53. PMID 24936685 DOI: 10.1016/J.Neuroimage.2014.06.009 |
0.545 |
|
| 2014 |
Cross AH, Wingerchuk DM, Weinshenker BG. Active and progressive: a new duality of MS classification. Neurology. 83: 206-7. PMID 24928117 DOI: 10.1212/Wnl.0000000000000601 |
0.448 |
|
| 2014 |
Cruz-Orengo L, Daniels BP, Dorsey D, Basak SA, Grajales-Reyes JG, McCandless EE, Piccio L, Schmidt RE, Cross AH, Crosby SD, Klein RS. Enhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility. The Journal of Clinical Investigation. 124: 2571-84. PMID 24812668 DOI: 10.1172/Jci73408 |
0.794 |
|
| 2014 |
Shin S, Walz KA, Archambault AS, Sim J, Bollman BP, Koenigsknecht-Talboo J, Cross AH, Holtzman DM, Wu GF. Apolipoprotein E mediation of neuro-inflammation in a murine model of multiple sclerosis. Journal of Neuroimmunology. 271: 8-17. PMID 24794230 DOI: 10.1016/J.Jneuroim.2014.03.010 |
0.35 |
|
| 2014 |
Lin TH, Spees WM, Chiang CW, Trinkaus K, Cross AH, Song SK. Diffusion fMRI detects white-matter dysfunction in mice with acute optic neuritis. Neurobiology of Disease. 67: 1-8. PMID 24632420 DOI: 10.1016/J.Nbd.2014.02.007 |
0.596 |
|
| 2014 |
Wen J, Cross AH, Yablonskiy DA. On the role of physiological fluctuations in quantitative gradient echo MRI: implications for GEPCI, QSM, and SWI. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. PMID 24482009 DOI: 10.1002/Mrm.25114 |
0.582 |
|
| 2014 |
Cross AH, Naismith RT. Established and novel disease-modifying treatments in multiple sclerosis. Journal of Internal Medicine. 275: 350-63. PMID 24444048 DOI: 10.1111/Joim.12203 |
0.773 |
|
| 2014 |
Waubant E, Cross A. MS and related disorders: Groundbreaking news The Lancet Neurology. 13: 11-13. PMID 24331785 DOI: 10.1016/S1474-4422(13)70284-9 |
0.37 |
|
| 2014 |
Luo J, Yablonskiy DA, Hildebolt CF, Lancia S, Cross AH. Gradient echo magnetic resonance imaging correlates with clinical measures and allows visualization of veins within multiple sclerosis lesions. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 349-55. PMID 23836876 DOI: 10.1177/1352458513495935 |
0.718 |
|
| 2014 |
Cross AH, Piccio L. Immunopathogenesis of Multiple Sclerosis Multiple Sclerosis and Cns Inflammatory Disorders. 10-17. DOI: 10.1002/9781118298633.ch2 |
0.79 |
|
| 2013 |
Fenoglio C, Ridolfi E, Cantoni C, De Riz M, Bonsi R, Serpente M, Villa C, Pietroboni AM, Naismith RT, Alvarez E, Parks BJ, Bresolin N, Cross AH, Piccio LM, Galimberti D, et al. Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1938-42. PMID 24277735 DOI: 10.1177/1352458513485654 |
0.79 |
|
| 2013 |
Angiari S, Rossi B, Piccio L, Zinselmeyer BH, Budui S, Zenaro E, Della Bianca V, Bach SD, Scarpini E, Bolomini-Vittori M, Piacentino G, Dusi S, Laudanna C, Cross AH, Miller MJ, et al. Regulatory T cells suppress the late phase of the immune response in lymph nodes through P-selectin glycoprotein ligand-1. Journal of Immunology (Baltimore, Md. : 1950). 191: 5489-500. PMID 24174617 DOI: 10.4049/Jimmunol.1301235 |
0.733 |
|
| 2013 |
Longbrake EE, Parks BJ, Cross AH. Monoclonal antibodies as disease modifying therapy in multiple sclerosis. Current Neurology and Neuroscience Reports. 13: 390. PMID 24027005 DOI: 10.1007/S11910-013-0390-Z |
0.435 |
|
| 2013 |
Cross AH, Klein RS. Comment: assessing humoral immunocompetence after alemtuzumab treatment in MS. Neurology. 81: 875. PMID 23925764 DOI: 10.1212/Wnl.0B013E3182A352C6 |
0.571 |
|
| 2013 |
Querol L, Clark PL, Bailey MA, Cotsapas C, Cross AH, Hafler DA, Kleinstein SH, Lee JY, Yaari G, Willis SN, O'Connor KC. Protein array-based profiling of CSF identifies RBPJ as an autoantigen in multiple sclerosis. Neurology. 81: 956-63. PMID 23921886 DOI: 10.1212/Wnl.0B013E3182A43B48 |
0.456 |
|
| 2013 |
Isobe N, Gourraud PA, Harbo HF, Caillier SJ, Santaniello A, Khankhanian P, Maiers M, Spellman S, Cereb N, Yang S, Pando MJ, Piccio L, Cross AH, De Jager PL, Cree BA, et al. Genetic risk variants in African Americans with multiple sclerosis. Neurology. 81: 219-27. PMID 23771490 DOI: 10.1212/Wnl.0B013E31829Bfe2F |
0.769 |
|
| 2013 |
Naismith RT, Xu J, Klawiter EC, Lancia S, Tutlam NT, Wagner JM, Qian P, Trinkaus K, Song SK, Cross AH. Spinal cord tract diffusion tensor imaging reveals disability substrate in demyelinating disease. Neurology. 80: 2201-9. PMID 23667060 DOI: 10.1212/Wnl.0B013E318296E8F1 |
0.8 |
|
| 2013 |
Piccio L, Cantoni C, Henderson JG, Hawiger D, Ramsbottom M, Mikesell R, Ryu J, Hsieh CS, Cremasco V, Haynes W, Dong LQ, Chan L, Galimberti D, Cross AH. Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis. European Journal of Immunology. 43: 2089-100. PMID 23640763 DOI: 10.1002/Eji.201242836 |
0.791 |
|
| 2013 |
Greenberg BM, Balcer L, Calabresi PA, Cree B, Cross A, Frohman T, Gold R, Havrdova E, Hemmer B, Kieseier BC, Lisak R, Miller A, Racke MK, Steinman L, Stuve O, et al. Interferon beta use and disability prevention in relapsing-remitting multiple sclerosis. Jama Neurology. 70: 248-51. PMID 23530268 DOI: 10.1001/Jamaneurol.2013.1017 |
0.35 |
|
| 2013 |
Alvarez E, Piccio L, Mikesell RJ, Klawiter EC, Parks BJ, Naismith RT, Cross AH. CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1204-8. PMID 23322500 DOI: 10.1177/1352458512473362 |
0.801 |
|
| 2013 |
Xu J, Shimony JS, Klawiter EC, Snyder AZ, Trinkaus K, Naismith RT, Benzinger TL, Cross AH, Song SK. Improved in vivo diffusion tensor imaging of human cervical spinal cord. Neuroimage. 67: 64-76. PMID 23178538 DOI: 10.1016/J.Neuroimage.2012.11.014 |
0.786 |
|
| 2012 |
Cross AH, Klein RS, Piccio L. Rituximab combination therapy in relapsing multiple sclerosis. Therapeutic Advances in Neurological Disorders. 5: 311-9. PMID 23139702 DOI: 10.1177/1756285612461165 |
0.828 |
|
| 2012 |
Qian P, Lancia S, Alvarez E, Klawiter EC, Cross AH, Naismith RT. Association of neuromyelitis optica with severe and intractable pain. Archives of Neurology. 69: 1482-7. PMID 22926050 DOI: 10.1001/Archneurol.2012.768 |
0.785 |
|
| 2012 |
Yablonskiy DA, Luo J, Sukstanskii AL, Iyer A, Cross AH. Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. 109: 14212-7. PMID 22891307 DOI: 10.1073/Pnas.1206037109 |
0.675 |
|
| 2012 |
Cross AH, Cross KA, Piccio L. Update on multiple sclerosis, its diagnosis and treatments. Clinical Chemistry and Laboratory Medicine : Cclm / Fescc. 50: 1203-10. PMID 22850053 DOI: 10.1515/Cclm-2011-0736 |
0.806 |
|
| 2012 |
Cross AH, Waubant E. Antibodies to potassium channels in multiple sclerosis. The New England Journal of Medicine. 367: 172-4. PMID 22784120 DOI: 10.1056/Nejme1204118 |
0.417 |
|
| 2012 |
Waubant E, Pelletier D, Mass M, Cohen JA, Kita M, Cross A, Bar-Or A, Vollmer T, Racke M, Stüve O, Schwid S, Goodman A, Kachuck N, Preiningerova J, Weinstock-Guttman B, et al. Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study. Neurology. 78: 1171-8. PMID 22459680 DOI: 10.1212/Wnl.0B013E31824F7Fdd |
0.322 |
|
| 2012 |
Klawiter EC, Xu J, Naismith RT, Benzinger TL, Shimony JS, Lancia S, Snyder AZ, Trinkaus K, Song SK, Cross AH. Increased radial diffusivity in spinal cord lesions in neuromyelitis optica compared with multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 1259-68. PMID 22354742 DOI: 10.1177/1352458512436593 |
0.827 |
|
| 2012 |
Luo J, Jagadeesan BD, Cross AH, Yablonskiy DA. Gradient echo plural contrast imaging--signal model and derived contrasts: T2*, T1, phase, SWI, T1f, FST2*and T2*-SWI. Neuroimage. 60: 1073-82. PMID 22305993 DOI: 10.1016/J.Neuroimage.2012.01.108 |
0.629 |
|
| 2012 |
Naismith RT, Xu J, Tutlam NT, Lancia S, Trinkaus K, Song SK, Cross AH. Diffusion tensor imaging in acute optic neuropathies: predictor of clinical outcomes. Archives of Neurology. 69: 65-71. PMID 21911658 DOI: 10.1001/Archneurol.2011.243 |
0.784 |
|
| 2012 |
Qian P, Cross A, Naismith R. Pain in Neuromyelitis Optica Is More Common, Disabling, and Refractory Compared to MS (P07.070) Neurology. 78: P07.070-P07.070. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P07.070 |
0.721 |
|
| 2012 |
Qian P, Lancia S, Patnaik R, Xu J, Cross A, Wolansky L, Cook S, Cadavid D, Naismith R. Ring-Enhancing Lesions in MS: Longitudinal Quantification by Diffusion Tensor and Magnetization Transfer Imaging (P03.039) Neurology. 78: P03.039-P03.039. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P03.039 |
0.757 |
|
| 2011 |
Wang Y, Wang Q, Haldar JP, Yeh FC, Xie M, Sun P, Tu TW, Trinkaus K, Klein RS, Cross AH, Song SK. Quantification of increased cellularity during inflammatory demyelination. Brain : a Journal of Neurology. 134: 3590-601. PMID 22171354 DOI: 10.1093/Brain/Awr307 |
0.665 |
|
| 2011 |
Qian P, Cross AH, Naismith RT. Lack of response to monoclonal antibody therapy in neuromyelitis optica. Archives of Neurology. 68: 1207-9. PMID 21911704 DOI: 10.1001/Archneurol.2011.194 |
0.734 |
|
| 2011 |
Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C, Hunt SE, Edkins S, Gray E, Booth DR, ... ... Cross AH, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 476: 214-9. PMID 21833088 DOI: 10.1038/Nature10251 |
0.758 |
|
| 2011 |
Monson NL, Cravens P, Hussain R, Harp CT, Cummings M, de Pilar Martin M, Ben LH, Do J, Lyons JA, Lovette-Racke A, Cross AH, Racke MK, Stüve O, Shlomchik M, Eagar TN. Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis. Plos One. 6: e17103. PMID 21359213 DOI: 10.1371/Journal.Pone.0017103 |
0.394 |
|
| 2011 |
Klawiter EC, Schmidt RE, Trinkaus K, Liang HF, Budde MD, Naismith RT, Song SK, Cross AH, Benzinger TL. Radial diffusivity predicts demyelination in ex vivo multiple sclerosis spinal cords. Neuroimage. 55: 1454-60. PMID 21238597 DOI: 10.1016/J.Neuroimage.2011.01.007 |
0.827 |
|
| 2011 |
Wu GF, Shindler KS, Allenspach EJ, Stephen TL, Thomas HL, Mikesell RJ, Cross AH, Laufer TM. Limited sufficiency of antigen presentation by dendritic cells in models of central nervous system autoimmunity. Journal of Autoimmunity. 36: 56-64. PMID 21095100 DOI: 10.1016/J.Jaut.2010.10.006 |
0.372 |
|
| 2011 |
Cross AH, Waubant E. MS and the B cell controversy. Biochimica Et Biophysica Acta. 1812: 231-8. PMID 20674743 DOI: 10.1016/J.Bbadis.2010.07.020 |
0.432 |
|
| 2010 |
Klawiter EC, Benzinger T, Roy A, Naismith RT, Parks BJ, Cross AH. Spinal cord ring enhancement in multiple sclerosis. Archives of Neurology. 67: 1395-8. PMID 21060017 DOI: 10.1001/Archneurol.2010.271 |
0.795 |
|
| 2010 |
Cross AH, Wu GF. Multiple sclerosis: oligoclonal bands still yield clues about multiple sclerosis. Nature Reviews. Neurology. 6: 588-9. PMID 21048798 DOI: 10.1038/Nrneurol.2010.142 |
0.439 |
|
| 2010 |
Klawiter EC, Piccio L, Lyons JA, Mikesell R, O'Connor KC, Cross AH. Elevated intrathecal myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis. Archives of Neurology. 67: 1102-8. PMID 20837855 DOI: 10.1001/Archneurol.2010.197 |
0.83 |
|
| 2010 |
Cross AH, Parks BJ. The four seasons of multiple sclerosis. Neurology. 75: 762-3. PMID 20805521 DOI: 10.1212/Wnl.0B013E3181F313Ec |
0.413 |
|
| 2010 |
Graham DB, Akilesh HM, Gmyrek GB, Piccio L, Gilfillan S, Sim J, Belizaire R, Carrero JA, Wang Y, Blaufuss GS, Sandoval G, Fujikawa K, Cross AH, Russell JH, Cella M, et al. ITAM signaling in dendritic cells controls T helper cell priming by regulating MHC class II recycling. Blood. 116: 3208-18. PMID 20634378 DOI: 10.1182/Blood-2009-10-250415 |
0.726 |
|
| 2010 |
Piccio L, Naismith RT, Trinkaus K, Klein RS, Parks BJ, Lyons JA, Cross AH. Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis. Archives of Neurology. 67: 707-14. PMID 20558389 DOI: 10.1001/Archneurol.2010.99 |
0.795 |
|
| 2010 |
Xie M, Tobin JE, Budde MD, Chen CI, Trinkaus K, Cross AH, McDaniel DP, Song SK, Armstrong RC. Rostrocaudal analysis of corpus callosum demyelination and axon damage across disease stages refines diffusion tensor imaging correlations with pathological features. Journal of Neuropathology and Experimental Neurology. 69: 704-16. PMID 20535036 DOI: 10.1097/Nen.0B013E3181E3De90 |
0.578 |
|
| 2010 |
Naismith RT, Piccio L, Lyons JA, Lauber J, Tutlam NT, Parks BJ, Trinkaus K, Song SK, Cross AH. Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: a 52-week phase II trial. Neurology. 74: 1860-7. PMID 20530322 DOI: 10.1212/Wnl.0B013E3181E24373 |
0.819 |
|
| 2010 |
Naismith RT, Xu J, Tutlam NT, Trinkaus K, Cross AH, Song SK. Radial diffusivity in remote optic neuritis discriminates visual outcomes. Neurology. 74: 1702-10. PMID 20498438 DOI: 10.1212/Wnl.0B013E3181E0434D |
0.747 |
|
| 2010 |
Naismith RT, Xu J, Tutlam NT, Scully PT, Trinkaus K, Snyder AZ, Song SK, Cross AH. Increased diffusivity in acute multiple sclerosis lesions predicts risk of black hole. Neurology. 74: 1694-701. PMID 20498437 DOI: 10.1212/Wnl.0B013E3181E042C4 |
0.786 |
|
| 2010 |
Sati P, Cross AH, Luo J, Hildebolt CF, Yablonskiy DA. In vivo quantitative evaluation of brain tissue damage in multiple sclerosis using gradient echo plural contrast imaging technique. Neuroimage. 51: 1089-97. PMID 20338247 DOI: 10.1016/J.Neuroimage.2010.03.045 |
0.784 |
|
| 2010 |
Zuvich RL, McCauley JL, Oksenberg JR, Sawcer SJ, De Jager PL, Aubin C, Cross AH, Piccio L, Aggarwal NT, Evans D, Hafler DA, Compston A, Hauser SL, Pericak-Vance MA, et al. Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility. Human Genetics. 127: 525-35. PMID 20112030 DOI: 10.1007/S00439-010-0789-4 |
0.76 |
|
| 2010 |
De Riz M, Galimberti D, Fenoglio C, Piccio LM, Scalabrini D, Venturelli E, Pietroboni A, Piola M, Naismith RT, Parks BJ, Fumagalli G, Bresolin N, Cross AH, Scarpini E. Cerebrospinal fluid progranulin levels in patients with different multiple sclerosis subtypes. Neuroscience Letters. 469: 234-6. PMID 19963041 DOI: 10.1016/J.Neulet.2009.12.002 |
0.817 |
|
| 2010 |
Pitt D, Gonzales E, Cross AH, Goldberg MP. Dysmyelinated axons in shiverer mice are highly vulnerable to alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor-mediated toxicity. Brain Research. 1309: 146-54. PMID 19896473 DOI: 10.1016/J.Brainres.2009.10.066 |
0.535 |
|
| 2010 |
Johnson BA, Wang J, Taylor EM, Caillier SJ, Herbert J, Khan OA, Cross AH, De Jager PL, Gourraud PA, Cree BC, Hauser SL, Oksenberg JR. Multiple sclerosis susceptibility alleles in African Americans. Genes and Immunity. 11: 343-50. PMID 19865102 DOI: 10.1038/Gene.2009.81 |
0.416 |
|
| 2009 |
Dace DS, Khan AA, Stark JL, Kelly J, Cross AH, Apte RS. Interleukin-10 overexpression promotes Fas-ligand-dependent chronic macrophage-mediated demyelinating polyneuropathy. Plos One. 4: e7121. PMID 19771172 DOI: 10.1371/Journal.Pone.0007121 |
0.312 |
|
| 2009 |
Klawiter EC, Cross AH, Naismith RT. The present efficacy of multiple sclerosis therapeutics: Is the new 66% just the old 33%? Neurology. 73: 984-90. PMID 19770475 DOI: 10.1212/Wnl.0B013E3181B9C8F7 |
0.811 |
|
| 2009 |
Naismith RT, Shepherd JB, Weihl CC, Tutlam NT, Cross AH. Acute and bilateral blindness due to optic neuropathy associated with copper deficiency. Archives of Neurology. 66: 1025-7. PMID 19667226 DOI: 10.1001/Archneurol.2009.70 |
0.705 |
|
| 2009 |
Naismith RT, Tutlam NT, Xu J, Shepherd JB, Klawiter EC, Song SK, Cross AH. Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis. Neurology. 73: 46-52. PMID 19564583 DOI: 10.1212/Wnl.0B013E3181Aaea32 |
0.771 |
|
| 2009 |
De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, Aggarwal NT, Piccio L, Raychaudhuri S, Tran D, Aubin C, Briskin R, Romano S, Baranzini SE, McCauley JL, ... ... Cross AH, et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nature Genetics. 41: 776-82. PMID 19525953 DOI: 10.1038/Ng.401 |
0.769 |
|
| 2009 |
Klawiter EC, Alvarez E, Xu J, Paciorkowski AR, Zhu L, Parks BJ, Cross AH, Naismith RT. NMO-IgG detected in CSF in seronegative neuromyelitis optica. Neurology. 72: 1101-3. PMID 19307546 DOI: 10.1212/01.Wnl.0000345066.57745.50 |
0.792 |
|
| 2009 |
Naismith RT, Tutlam NT, Xu J, Klawiter EC, Shepherd J, Trinkaus K, Song SK, Cross AH. Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology. 72: 1077-82. PMID 19307541 DOI: 10.1212/01.Wnl.0000345042.53843.D5 |
0.818 |
|
| 2009 |
Budde MD, Xie M, Cross AH, Song SK. Axial diffusivity is the primary correlate of axonal injury in the experimental autoimmune encephalomyelitis spinal cord: a quantitative pixelwise analysis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 2805-13. PMID 19261876 DOI: 10.1523/Jneurosci.4605-08.2009 |
0.604 |
|
| 2009 |
Fenoglio C, Scalabrini D, Piccio L, De Riz M, Venturelli E, Cortini F, Villa C, Serpente M, Parks B, Rinker J, Cross AH, Bresolin N, Scarpini E, Galimberti D. Candidate gene analysis of selectin cluster in patients with multiple sclerosis. Journal of Neurology. 256: 832-3. PMID 19240957 DOI: 10.1007/S00415-009-5016-7 |
0.784 |
|
| 2009 |
Naismith RT, Xu J, Tutlam NT, Snyder A, Benzinger T, Shimony J, Shepherd J, Trinkaus K, Cross AH, Song SK. Disability in optic neuritis correlates with diffusion tensor-derived directional diffusivities. Neurology. 72: 589-94. PMID 19073948 DOI: 10.1212/01.wnl.0000335766.22758.cd |
0.749 |
|
| 2008 |
Piccio L, Buonsanti C, Cella M, Tassi I, Schmidt RE, Fenoglio C, Rinker J, Naismith RT, Panina-Bordignon P, Passini N, Galimberti D, Scarpini E, Colonna M, Cross AH. Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation. Brain : a Journal of Neurology. 131: 3081-91. PMID 18790823 DOI: 10.1093/Brain/Awn217 |
0.829 |
|
| 2008 |
Xu J, Sun SW, Naismith RT, Snyder AZ, Cross AH, Song SK. Assessing optic nerve pathology with diffusion MRI: from mouse to human. Nmr in Biomedicine. 21: 928-40. PMID 18756587 DOI: 10.1002/Nbm.1307 |
0.77 |
|
| 2008 |
Piccio L, Stark JL, Cross AH. Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis. Journal of Leukocyte Biology. 84: 940-8. PMID 18678605 DOI: 10.1189/Jlb.0208133 |
0.766 |
|
| 2008 |
McCandless EE, Piccio L, Woerner BM, Schmidt RE, Rubin JB, Cross AH, Klein RS. Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis. The American Journal of Pathology. 172: 799-808. PMID 18276777 DOI: 10.2353/Ajpath.2008.070918 |
0.823 |
|
| 2008 |
Sun SW, Liang HF, Cross AH, Song SK. Evolving Wallerian degeneration after transient retinal ischemia in mice characterized by diffusion tensor imaging. Neuroimage. 40: 1-10. PMID 18187343 DOI: 10.1016/J.Neuroimage.2007.11.049 |
0.565 |
|
| 2008 |
Budde MD, Kim JH, Liang HF, Russell JH, Cross AH, Song SK. Axonal injury detected by in vivo diffusion tensor imaging correlates with neurological disability in a mouse model of multiple sclerosis. Nmr in Biomedicine. 21: 589-97. PMID 18041806 DOI: 10.1002/Nbm.1229 |
0.587 |
|
| 2007 |
Sun SW, Liang HF, Schmidt RE, Cross AH, Song SK. Selective vulnerability of cerebral white matter in a murine model of multiple sclerosis detected using diffusion tensor imaging. Neurobiology of Disease. 28: 30-8. PMID 17683944 DOI: 10.1016/J.Nbd.2007.06.011 |
0.573 |
|
| 2007 |
Rinker JR, Trinkaus K, Naismith RT, Cross AH. Higher IgG index found in African Americans versus Caucasians with multiple sclerosis. Neurology. 69: 68-72. PMID 17606883 DOI: 10.1212/01.Wnl.0000265057.79843.D9 |
0.805 |
|
| 2007 |
Klawiter EC, Cross AH. B cells: no longer the nondominant arm of multiple sclerosis. Current Neurology and Neuroscience Reports. 7: 231-8. PMID 17488589 DOI: 10.1007/S11910-007-0035-1 |
0.721 |
|
| 2007 |
Goodman AD, Cohen JA, Cross A, Vollmer T, Rizzo M, Cohen R, Marinucci L, Blight AR. Fampridine-SR in multiple sclerosis: A randomized, double-blind, placebo-controlled, dose-ranging study Multiple Sclerosis. 13: 357-368. PMID 17439905 DOI: 10.1177/1352458506069538 |
0.358 |
|
| 2007 |
Piccio L, Buonsanti C, Mariani M, Cella M, Gilfillan S, Cross AH, Colonna M, Panina-Bordignon P. Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis. European Journal of Immunology. 37: 1290-301. PMID 17407101 DOI: 10.1002/Eji.200636837 |
0.767 |
|
| 2007 |
Budde MD, Kim JH, Liang HF, Schmidt RE, Russell JH, Cross AH, Song SK. Toward accurate diagnosis of white matter pathology using diffusion tensor imaging. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 57: 688-95. PMID 17390365 DOI: 10.1002/Mrm.21200 |
0.589 |
|
| 2007 |
Lees JR, Cross AH. A little stress is good: IFN-gamma, demyelination, and multiple sclerosis. The Journal of Clinical Investigation. 117: 297-9. PMID 17273549 DOI: 10.1172/Jci31254 |
0.425 |
|
| 2007 |
Wolinsky JS, Narayana PA, O'Connor P, Coyle PK, Ford C, Johnson K, Miller A, Pardo L, Kadosh S, Ladkani D, Kastrukoff L, Duquette P, Freedman M, Debouverie M, Lubetski C, ... ... Cross A, et al. Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial Annals of Neurology. 61: 14-24. PMID 17262850 DOI: 10.1002/Ana.21079 |
0.572 |
|
| 2007 |
Naismith RT, Cross AH. Magnetic resonance imaging of multiple sclerosis Continuum Lifelong Learning in Neurology. 13: 117-143. DOI: 10.1212/01.CON.0000293643.43858.9a |
0.708 |
|
| 2007 |
Rinker JR, Cross AH. Diagnosis and differential diagnosis of multiple sclerosis Continuum Lifelong Learning in Neurology. 13: 13-34. DOI: 10.1212/01.CON.0000293639.90492.59 |
0.562 |
|
| 2007 |
Benzinger TLS, Cross AH, Xu J, Naismith R, Sun SW, Song SK. Directional diffusivity as a magnetic resonance (MR) biomarker in demyelinating disease Proceedings of Spie - the International Society For Optical Engineering. 6759. DOI: 10.1117/12.740133 |
0.748 |
|
| 2006 |
Naismith RT, Trinkaus K, Cross AH. Phenotype and prognosis in African-Americans with multiple sclerosis: a retrospective chart review. Multiple Sclerosis (Houndmills, Basingstoke, England). 12: 775-81. PMID 17263006 DOI: 10.1177/1352458506070923 |
0.778 |
|
| 2006 |
Rinker JR, Trinkaus K, Cross AH. Elevated CSF free kappa light chains correlate with disability prognosis in multiple sclerosis. Neurology. 67: 1288-90. PMID 17030770 DOI: 10.1212/01.Wnl.0000238107.31364.21 |
0.649 |
|
| 2006 |
Cross AH, Stark JL, Lauber J, Ramsbottom MJ, Lyons JA. Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients. Journal of Neuroimmunology. 180: 63-70. PMID 16904756 DOI: 10.1016/J.Jneuroim.2006.06.029 |
0.378 |
|
| 2006 |
Sun SW, Liang HF, Le TQ, Armstrong RC, Cross AH, Song SK. Differential sensitivity of in vivo and ex vivo diffusion tensor imaging to evolving optic nerve injury in mice with retinal ischemia. Neuroimage. 32: 1195-204. PMID 16797189 DOI: 10.1016/J.Neuroimage.2006.04.212 |
0.535 |
|
| 2006 |
Cross AH, Ramsbottom MJ, Lyons JA. NOS2 regulates cytokine production and VLA-4 expression in experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 173: 79-86. PMID 16448705 DOI: 10.1016/J.Jneuroim.2005.11.022 |
0.332 |
|
| 2006 |
Sun SW, Liang HF, Trinkaus K, Cross AH, Armstrong RC, Song SK. Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 55: 302-8. PMID 16408263 DOI: 10.1002/Mrm.20774 |
0.562 |
|
| 2006 |
Stark JL, Cross AH. Differential expression of suppressors of cytokine signaling-1 and -3 and related cytokines in central nervous system during remitting versus non-remitting forms of experimental autoimmune encephalomyelitis. International Immunology. 18: 347-53. PMID 16373362 DOI: 10.1093/Intimm/Dxh373 |
0.311 |
|
| 2006 |
Kim JH, Budde MD, Liang HF, Klein RS, Russell JH, Cross AH, Song SK. Detecting axon damage in spinal cord from a mouse model of multiple sclerosis. Neurobiology of Disease. 21: 626-32. PMID 16298135 DOI: 10.1016/J.Nbd.2005.09.009 |
0.655 |
|
| 2005 |
Naismith RT, Cross AH. Multiple sclerosis and black holes: connecting the pixels. Archives of Neurology. 62: 1666-8. PMID 16286537 DOI: 10.1001/Archneur.62.11.1666 |
0.735 |
|
| 2005 |
Cross AH, Stark JL. Humoral immunity in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis. Immunologic Research. 32: 85-97. PMID 16106061 DOI: 10.1385/Ir:32:1-3:085 |
0.462 |
|
| 2005 |
Song SK, Yoshino J, Le TQ, Lin SJ, Sun SW, Cross AH, Armstrong RC. Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage. 26: 132-40. PMID 15862213 DOI: 10.1016/J.Neuroimage.2005.01.028 |
0.592 |
|
| 2004 |
Naismith RT, Cross AH. Does the hepatitis B vaccine cause multiple sclerosis? Neurology. 63: 772-3. PMID 15365121 DOI: 10.1212/01.Wnl.0000137887.24504.30 |
0.75 |
|
| 2004 |
Attarian HP, Brown KM, Duntley SP, Carter JD, Cross AH. The relationship of sleep disturbances and fatigue in multiple sclerosis. Archives of Neurology. 61: 525-8. PMID 15096400 DOI: 10.1001/Archneur.61.4.525 |
0.399 |
|
| 2003 |
Song SK, Sun SW, Ju WK, Lin SJ, Cross AH, Neufeld AH. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage. 20: 1714-22. PMID 14642481 DOI: 10.1016/J.Neuroimage.2003.07.005 |
0.553 |
|
| 2003 |
Cross AH, Golumbek PT. Neurologic manifestations of celiac disease: proven, or just a gut feeling? Neurology. 60: 1566-8. PMID 12771239 DOI: 10.1212/01.Wnl.0000067475.16126.5F |
0.31 |
|
| 2002 |
Lyons JA, Ramsbottom MJ, Trotter JL, Cross AH. Identification of the encephalitogenic epitopes of CNS proteolipid protein in BALB/c mice. Journal of Autoimmunity. 19: 195-201. PMID 12473240 DOI: 10.1006/Jaut.2002.0619 |
0.609 |
|
| 2002 |
Song SK, Sun SW, Ramsbottom MJ, Chang C, Russell J, Cross AH. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage. 17: 1429-36. PMID 12414282 DOI: 10.1006/Nimg.2002.1267 |
0.548 |
|
| 2002 |
Lyons JA, Ramsbottom MJ, Cross AH. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. European Journal of Immunology. 32: 1905-13. PMID 12115610 DOI: 10.1002/1521-4141(200207)32:7<1905::Aid-Immu1905>3.0.Co;2-L |
0.351 |
|
| 2001 |
Cross AH. Landmark papers in multiple sclerosis. Neurology. 57: S1-2. PMID 11902588 |
0.316 |
|
| 2001 |
Avasarala JR, Cross AH, Trotter JL. Oligoclonal band number as a marker for prognosis in multiple sclerosis. Archives of Neurology. 58: 2044-5. PMID 11735778 DOI: 10.1001/Archneur.58.12.2044 |
0.68 |
|
| 2001 |
Jacobson S, Cross A. Association of Chlamydia pneumoniae and multiple sclerosis: Stage two? Neurology. 56: 1128-1129. PMID 11342674 DOI: 10.1212/Wnl.56.9.1128 |
0.446 |
|
| 2001 |
Cross AH, Trotter JL, Lyons J. B cells and antibodies in CNS demyelinating disease. Journal of Neuroimmunology. 112: 1-14. PMID 11108928 DOI: 10.1016/S0165-5728(00)00409-4 |
0.664 |
|
| 2001 |
Cross AH, Landau WM. John L. Trotter, MD (1943-2001) Neurology. 57: 1534-1535. DOI: 10.1212/Wnl.57.9.1534 |
0.341 |
|
| 2001 |
Naismith RT, Cross AH. Multiple sclerosis: Current treatment and future therapeutic directions Neuroscience News. 4: 48-57. |
0.723 |
|
| 2000 |
Segal BM, Cross AH. Fas(t) track to apoptosis in MS: TNF receptors may suppress or potentiate CNS demyelination. Neurology. 55: 906-7. PMID 11061241 DOI: 10.1212/Wnl.55.7.906 |
0.363 |
|
| 2000 |
Cross AH, Ku G. Astrocytes and central nervous system endothelial cells do not express B7-1 (CD80) or B7-2 (CD86) immunoreactivity during experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 110: 76-82. PMID 11024536 DOI: 10.1016/S0165-5728(00)00327-1 |
0.33 |
|
| 2000 |
Devere TR, Trotter JL, Cross AH. Acute aphasia in multiple sclerosis. Archives of Neurology. 57: 1207-9. PMID 10927803 DOI: 10.1001/Archneur.57.8.1207 |
0.666 |
|
| 2000 |
Cross AH, San M, Stern MK, Keeling RM, Salvemini D, Misko TP. A catalyst of peroxynitrite decomposition inhibits murine experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 107: 21-8. PMID 10808047 DOI: 10.1016/S0165-5728(00)00242-3 |
0.366 |
|
| 2000 |
Cross AH. MS: the return of the B cell. Neurology. 54: 1214-5. PMID 10746584 DOI: 10.1212/Wnl.54.6.1214 |
0.471 |
|
| 1999 |
Sabelko-Downes KA, Russell JH, Cross AH. Role of Fas--FasL interactions in the pathogenesis and regulation of autoimmune demyelinating disease. Journal of Neuroimmunology. 100: 42-52. PMID 10695714 DOI: 10.1016/S0165-5728(99)00191-5 |
0.442 |
|
| 1999 |
Lyons JA, San M, Happ MP, Cross AH. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. European Journal of Immunology. 29: 3432-9. PMID 10556797 DOI: 10.1002/(Sici)1521-4141(199911)29:11<3432::Aid-Immu3432>3.0.Co;2-2 |
0.344 |
|
| 1999 |
Trotter JL, Keadle TL, Lauber JM, Dong WL, Cross AH. Increased frequency of recognition of delipidated versus intact CNS myelin in multiple sclerosis and control subjects. Journal of the Neurological Sciences. 166: 23-7. PMID 10465495 DOI: 10.1016/S0022-510X(99)00106-9 |
0.669 |
|
| 1999 |
Cross AH, San M, Keeling RM, Karr RW. CTLA-4-Fc treatment of ongoing EAE improves recovery, but has no effect upon relapse rate. Implications for the mechanisms involved in disease perpetuation. Journal of Neuroimmunology. 96: 144-7. PMID 10337912 DOI: 10.1016/S0165-5728(99)00015-6 |
0.359 |
|
| 1999 |
Benson JM, Stuckman SS, Cox KL, Wardrop RM, Gienapp IE, Cross AH, Trotter JL, Whitacre CC. Oral administration of myelin basic protein is superior to myelin in suppressing established relapsing experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 162: 6247-54. PMID 10229871 |
0.611 |
|
| 1999 |
Sabelko-Downes KA, Cross AH, Russell JH. Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis. The Journal of Experimental Medicine. 189: 1195-205. PMID 10209037 DOI: 10.1084/Jem.189.8.1195 |
0.351 |
|
| 1998 |
Cross AH, Manning PT, Keeling RM, Schmidt RE, Misko TP. Peroxynitrite formation within the central nervous system in active multiple sclerosis. Journal of Neuroimmunology. 88: 45-56. PMID 9688323 DOI: 10.1016/S0165-5728(98)00078-2 |
0.454 |
|
| 1998 |
Cross AH, Antel JP. Antibodies to beta-interferons in multiple sclerosis: can we neutralize the controversy? Neurology. 50: 1206-8. PMID 9595962 DOI: 10.1212/Wnl.50.5.1206 |
0.367 |
|
| 1998 |
Rose JW, Hill KE, Wada Y, Kurtz CI, Tsunoda I, Fujinami RS, Cross AH. Nitric oxide synthase inhibitor, aminoguanidine, reduces inflammation and demyelination produced by Theiler's virus infection. Journal of Neuroimmunology. 81: 82-9. PMID 9521609 DOI: 10.1016/S0165-5728(97)00162-8 |
0.309 |
|
| 1998 |
Whitacre C, Benson J, Cross A, Trotter J. The oral administration of myelin basic protein (MBP) but not myelin suppresses chronic relapsing experimental autoimmune encephalomyelitis (EAE) Journal of Neuroimmunology. 90: 86. DOI: 10.1016/S0165-5728(98)91693-9 |
0.636 |
|
| 1998 |
Cross A, Lyons J, Keeling R, San M, Ku G, Racke M. Expression of T cell co-stimulatory molecules within the CNS in inflammatory demyelination Journal of Neuroimmunology. 90: 3. DOI: 10.1016/S0165-5728(98)91213-9 |
0.32 |
|
| 1997 |
Cross AH, Manning PT, Stern MK, Misko TP. Evidence for the production of peroxynitrite in inflammatory CNS demyelination. Journal of Neuroimmunology. 80: 121-30. PMID 9413267 DOI: 10.1016/S0165-5728(97)00145-8 |
0.31 |
|
| 1997 |
Trotter JL, Damico CA, Cross AH, Pelfrey CM, Karr RW, Fu XT, McFarland HF. HPRT mutant T-cell lines from multiple sclerosis patients recognize myelin proteolipid protein peptides. Journal of Neuroimmunology. 75: 95-103. PMID 9143242 DOI: 10.1016/S0165-5728(97)00007-6 |
0.729 |
|
| 1996 |
Krupp L, Coyle P, Grimson R, Miller A, Cross AH. Reply from the Authors: Fatigue in MS Neurology. 47: 1351-1351. DOI: 10.1212/Wnl.47.5.1351-C |
0.381 |
|
| 1995 |
Misko TP, Trotter JL, Cross AH. Mediation of inflammation by encephalitogenic cells: interferon gamma induction of nitric oxide synthase and cyclooxygenase 2. Journal of Neuroimmunology. 61: 195-204. PMID 7593555 DOI: 10.1016/0165-5728(95)00091-F |
0.627 |
|
| 1995 |
Cross AH, Girard TJ, Giacoletto KS, Evans RJ, Keeling RM, Lin RF, Trotter JL, Karr RW. Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation. The Journal of Clinical Investigation. 95: 2783-9. PMID 7539461 DOI: 10.1172/Jci117982 |
0.645 |
|
| 1995 |
Trotter JL, Damico CA, Trotter AL, Collins KG, Cross AH. Interleukin-2 binding proteins in sera from normal subjects and multiple sclerosis patients. Neurology. 45: 1971-4. PMID 7501143 DOI: 10.1212/Wnl.45.11.1971 |
0.61 |
|
| 1995 |
Krupp LB, Coyle PK, Doscher C, Miller A, Cross AH, Jandorf L, Halper J, Johnson B, Morgante L, Grimson R. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology. 45: 1956-61. PMID 7501140 DOI: 10.1212/Wnl.45.11.1956 |
0.403 |
|
| 1994 |
Cross AH, Misko TP, Lin RF, Hickey WF, Trotter JL, Tilton RG. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. The Journal of Clinical Investigation. 93: 2684-90. PMID 7515395 DOI: 10.1172/Jci117282 |
0.646 |
|
| 1993 |
Monastra G, Cross AH, Bruni A, Raine CS. Phosphatidylserine, a putative inhibitor of tumor necrosis factor, prevents autoimmune demyelination. Neurology. 43: 153-63. PMID 8423880 DOI: 10.1212/Wnl.43.1_Part_1.153 |
0.507 |
|
| 1993 |
Lin RF, Lin TS, Tilton RG, Cross AH. Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic resonance study. The Journal of Experimental Medicine. 178: 643-8. PMID 8393479 DOI: 10.1084/Jem.178.2.643 |
0.418 |
|
| 1993 |
Cross AH, Trotter JL, Hart WM. Caveat regarding immunoglobulin therapy in multiple sclerosis. Annals of Neurology. 33: 660-1. PMID 8338598 DOI: 10.1002/Ana.410330619 |
0.654 |
|
| 1993 |
Cannella B, Cross AH, Raine CS. Anti-adhesion molecule therapy in experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 46: 43-55. PMID 8103061 DOI: 10.1016/0165-5728(93)90232-N |
0.484 |
|
| 1993 |
Cross AH, O'Mara T, Raine CS. Chronologic localization of myelin-reactive cells in the lesions of relapsing EAE: implications for the study of multiple sclerosis. Neurology. 43: 1028-33. PMID 7684116 DOI: 10.1212/Wnl.43.5.1028 |
0.569 |
|
| 1993 |
Rajan AJ, Cross AH, Raine CS, Diamond B. Multiple encephalitogenic peptides of myelin basic protein in A.CA mice. Cellular Immunology. 147: 378-87. PMID 7680964 DOI: 10.1006/Cimm.1993.1077 |
0.52 |
|
| 1993 |
Cross AH, Tuohy VK, Raine CS. Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination. Cellular Immunology. 146: 261-9. PMID 7513616 DOI: 10.1006/Cimm.1993.1025 |
0.513 |
|
| 1992 |
Cross AH, Ishikawa S, Raine CS, Diamond B. Autoimmune demyelination in transgenic E alpha d-positive A.CA mice. Comparison with E-negative A.CA mice. Laboratory Investigation; a Journal of Technical Methods and Pathology. 66: 598-607. PMID 1573854 |
0.413 |
|
| 1992 |
Cross AH. Immune cell traffic control and the central nervous system Seminars in Neuroscience. 4: 213-219. DOI: 10.1016/1044-5765(92)90004-L |
0.309 |
|
| 1992 |
Cross AH. Treatment of multiple sclerosis. Trial design, results and future perspectives Journal of Neuroimmunology. 41: 249. DOI: 10.1016/0165-5728(92)90077-X |
0.327 |
|
| 1991 |
Cannella B, Cross AH, Raine CS. Relapsing autoimmune demyelination: a role for vascular addressins. Journal of Neuroimmunology. 35: 295-300. PMID 1955571 DOI: 10.1016/0165-5728(91)90183-8 |
0.503 |
|
| 1991 |
Cross AH, Raine CS. Central nervous system endothelial cell-polymorphonuclear cell interactions during autoimmune demyelination. The American Journal of Pathology. 139: 1401-9. PMID 1750510 |
0.411 |
|
| 1991 |
Selmaj K, Raine CS, Cross AH. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Annals of Neurology. 30: 694-700. PMID 1722388 DOI: 10.1002/Ana.410300510 |
0.545 |
|
| 1991 |
Selmaj K, Cross AH, Farooq M, Brosnan CF, Raine CS. Non-specific oligodendrocyte cytotoxicity mediated by soluble products of activated T cell lines. Journal of Neuroimmunology. 35: 261-71. PMID 1720136 DOI: 10.1016/0165-5728(91)90180-F |
0.607 |
|
| 1991 |
Cross AH, Cannella B, Brosnan CF, Raine CS. Hypothesis: antigen-specific T cells prime central nervous system endothelium for recruitment of nonspecific inflammatory cells to effect autoimmune demyelination. Journal of Neuroimmunology. 33: 237-44. PMID 1714920 DOI: 10.1016/0165-5728(91)90111-J |
0.635 |
|
| 1991 |
Cross AH, Hashim GA, Raine CS. Adoptive transfer of experimental allergic encephalomyelitis and localization of the encephalitogenic epitope in the SWR mouse. Journal of Neuroimmunology. 31: 59-66. PMID 1701448 DOI: 10.1016/0165-5728(91)90087-N |
0.461 |
|
| 1991 |
Cannella B, Cross AH, Raine CS. Adhesion-related molecules in the central nervous system. Upregulation correlates with inflammatory cell influx during relapsing experimental autoimmune encephalomyelitis. Laboratory Investigation; a Journal of Technical Methods and Pathology. 65: 23-31. PMID 1677055 |
0.439 |
|
| 1991 |
Cross AH, Cannella B, Raine CS. Lymphocyte/vasculature interactions underlying formation of autoimmune demyelinating lesions Journal of Neuroimmunology. 35: 154. DOI: 10.1016/0165-5728(91)91130-5 |
0.498 |
|
| 1991 |
Cannella B, Cross AH, Raine CS. Co-expression of adhesion molecules during GNS inflammation in murine EAE Journal of Neuroimmunology. 35: 152. DOI: 10.1016/0165-5728(91)91127-X |
0.436 |
|
| 1991 |
Selmai K, Cross AH, Raine CS. Anti-tumor necrosis factor (anti-TNF) therapy abrogates autoimmune demyelination: New therapeutic implications for multiple sclerosis Journal of Neuroimmunology. 35: 113. DOI: 10.1016/0165-5728(91)91049-I |
0.504 |
|
| 1991 |
Monastra G, Cross A, Bruni A, Raine C. Phosphatidylserine-induced inhibition of experimental auto-immune encephalomyelitis (EAE) in mice Journal of Neuroimmunology. 35: 59. DOI: 10.1016/0165-5728(91)90944-3 |
0.442 |
|
| 1991 |
Cross AH. McAlpine's multiple sclerosis Journal of Neuroimmunology. 34: 87. DOI: 10.1016/0165-5728(91)90103-E |
0.399 |
|
| 1990 |
Raine CS, Cross AH. T cell autoimmunity in the central nervous system--a new twist at an old rope. Laboratory Investigation; a Journal of Technical Methods and Pathology. 62: 133-4. PMID 2304329 |
0.402 |
|
| 1990 |
Raine CS, Lee SC, Scheinberg LC, Duijvestin AM, Cross AH. Adhesion molecules on endothelial cells in the central nervous system: an emerging area in the neuroimmunology of multiple sclerosis. Clinical Immunology and Immunopathology. 57: 173-87. PMID 2208803 DOI: 10.1016/0090-1229(90)90032-L |
0.732 |
|
| 1990 |
Cannella B, Cross AH, Raine CS. Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system. The Journal of Experimental Medicine. 172: 1521-4. PMID 2172438 DOI: 10.1084/Jem.172.5.1521 |
0.503 |
|
| 1990 |
Raine CS, Cannella B, Duijvestijn AM, Cross AH. Homing to central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination. Laboratory Investigation; a Journal of Technical Methods and Pathology. 63: 476-89. PMID 1700193 |
0.443 |
|
| 1990 |
Cross AH, Cannella B, Brosnan CF, Raine CS. Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Laboratory Investigation; a Journal of Technical Methods and Pathology. 63: 162-70. PMID 1696331 |
0.6 |
|
| 1990 |
Cross AH, Dolich S, Raine CS. Antigen processing of myelin basic protein is required prior to recognition by T cells inducing EAE. Cellular Immunology. 129: 22-31. PMID 1694732 DOI: 10.1016/0008-8749(90)90183-R |
0.521 |
|
| 1990 |
Cross AH, Raine CS. Serial adoptive transfer of murine experimental allergic encephalomyelitis: successful transfer is dependent on active disease in the donor. Journal of Neuroimmunology. 28: 27-37. PMID 1692846 DOI: 10.1016/0165-5728(90)90038-O |
0.53 |
|
| 1990 |
Lee SC, Cross AH, Raine CS. HIGH ENDOTHELIAL VENULE ANTIGEN EXPRESSION IN MULTIPLE SCLEROSIS LESIONS Journal of Neuropathology and Experimental Neurology. 49: 288. DOI: 10.1097/00005072-199005000-00088 |
0.523 |
|
| 1990 |
Cross AH, Cannella B, Raine CS. LYMPHOCYTE/ENDOTHELIAL CELL INTERACTIONS DURING INITIAL STAGES OF EXPERIMENTAL AUTOIMMUNE ENCEFHALOMYELITIS (EAE) Journal of Neuropathology and Experimental Neurology. 49: 287. DOI: 10.1097/00005072-199005000-00086 |
0.441 |
|
| 1990 |
Cannella B, Cross A, Raine CS. CHRONOLOGIC EXPRESSION OF ADHESION MARKERS IN THE CNS DURING ADOPTIVELY-TRANSFERRED EAE Journal of Neuropathology and Experimental Neurology. 49: 287. DOI: 10.1097/00005072-199005000-00084 |
0.455 |
|
| 1989 |
Raine CS, Cross AH. Axonal dystrophy as a consequence of long-term demyelination. Laboratory Investigation; a Journal of Technical Methods and Pathology. 60: 714-25. PMID 2716284 |
0.426 |
|
| 1989 |
Cannella B, Cross AH, Raine CS. UP-REGULATION BY CYTOKINES OF CLASS II MHC EXPRESSION ON GLIAL CELLS IN ORGANOTYPIC CNS CULTURES Journal of Neuropathology and Experimental Neurology. 48: 324. DOI: 10.1097/00005072-198905000-00076 |
0.438 |
|
| 1989 |
Raine CS, Cross AH. AXONAL ATTRITION IN DEMYELINATED PLAQUES Journal of Neuropathology and Experimental Neurology. 48: 323. DOI: 10.1097/00005072-198905000-00073 |
0.472 |
|
| 1989 |
Selmaj K, Brosnan CF, Cross AH, Faroog M, Norton WT, Raine CS. MYELIN BASIC PROTEIN (MBP)-SPECIFIC T-CELLS ARE CYTOTOXIC FOR OLIGODENDROCYTES Journal of Neuropathology and Experimental Neurology. 48: 323. DOI: 10.1097/00005072-198905000-00072 |
0.623 |
|
| 1989 |
Cross AH, Raine CS. SERIAL TRANSFER OF 14C-LABELED LYMPHOCYTES IN ADOPTIVELY TRANSFERRED EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS (EAE) Journal of Neuropathology and Experimental Neurology. 48: 322. DOI: 10.1097/00005072-198905000-00070 |
0.428 |
|
| 1987 |
Cross AH, McCarron R, McFarlin DE, Raine CS. Adoptively transferred acute and chronic relapsing autoimmune encephalomyelitis in the PL/J mouse and observations on altered pathology by intercurrent virus infection. Laboratory Investigation; a Journal of Technical Methods and Pathology. 57: 499-512. PMID 2824923 |
0.435 |
|
| 1986 |
Cross A, McFarlin DE, Raine CS. ADOPTIVELY-TRANSFERRED CHRONIC RELAPSING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS (EAE) IN THE PL/J MOUSE Journal of Neuropathology and Experimental Neurology. 45: 354. DOI: 10.1097/00005072-198605000-00120 |
0.454 |
|
| Show low-probability matches. |